Although low levels of CD3+, CD4+, and CD8+ T cells were identified as significant risk factors for CKD progression, we only focused on the baseline levels of T-lymphocytes and did not continue to track changes after dialysis. This evidence concerns the gene CD4 and chronic kidney disease.